Comparing Healthcare Costs Associated with Oral and Subcutaneous Methotrexate or Biologic Therapy for Rheumatoid Arthritis in the United States

Схожие документы

• Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
  по: Curtis, J. R., et al.
  Опубликовано: (2016)
• Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
  по: Bianchi, Gerolamo, et al.
  Опубликовано: (2016)
• Using subcutaneous methotrexate to prolong duration of methotrexate therapy in rheumatoid arthritis
  по: Harris, Emily, et al.
  Опубликовано: (2018)
• Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration
  по: Schiff, Michael H, et al.
  Опубликовано: (2014)
• Methotrexate oral or subcutaneous for rheumatoid arthritis (MOOSE): study protocol for a multi-centre randomised trial
  по: Sarah McClure, et al.
  Опубликовано: (2025-11-01)